ResMed Inc., a Delaware corporation, was founded in March 1994. The company is a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory diseases, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular diseases and other chronic diseases. The company's products and solutions are designed to improve patients' quality of life, reduce the impact of chronic diseases, and reduce health care costs as the global health care system continues to drive the transfer of care from hospitals to homes and low-cost environments. The company's cloud-based digital software health applications, as well as devices, are designed to provide connected care to improve patient outcomes and increase customer efficiency.
